Keyphrases
Induced Pluripotent Stem Cells (iPSCs)
100%
Cardiomyocytes
100%
Tissue-engineered Constructs
100%
Cardiac Patch
100%
Biomaterials
60%
Human Induced Pluripotent Stem Cell-derived Cardiomyocytes (hiPSC-CMs)
60%
Heart Disease
40%
Regenerative Medicine
40%
Growth Factors
40%
Delivery System
40%
Cardiac Regeneration
40%
Infarct Size
40%
Cell Engraftment
40%
Adverse Events
20%
Rat Model
20%
Literature Search
20%
Safety Profile
20%
Functional Capacity
20%
Ischemic Heart Disease
20%
Neovascularization
20%
Outcome-based
20%
In Vivo Effects
20%
Tissue Characteristics
20%
Inflammatory Process
20%
Functional Traits
20%
Efficient Delivery
20%
Functional Change
20%
In Vivo Applications
20%
Lay Summary
20%
Functional Safety
20%
Paracrine Mechanism
20%
Cell Lineage
20%
Cardiac Cells
20%
Human Trials
20%
Engineered Cardiac Tissue
20%
Patch Characteristics
20%
Porcine Model
20%
Left Ventricular Systolic Function
20%
Non-cardiomyocytes
20%
Medicine and Dentistry
Cardiac Muscle Cell
100%
Engineered Tissue
100%
Induced Pluripotent Stem Cell
100%
Biocompatible Material
60%
Cardiovascular Disease
40%
Engraftment
40%
Growth Factor
40%
Infarction
40%
Tissue Regeneration
40%
Adverse Event
20%
In Vitro
20%
Functional Status
20%
Ischemic Heart Disease
20%
Serositis
20%
Systolic Function
20%
Cell Lineage
20%
Pharmacology, Toxicology and Pharmaceutical Science
Biomaterial
100%
Growth Factor
66%
Infarction
66%
Cardiovascular Disease
66%
Functional Status
33%
Adverse Event
33%
Ischemic Heart Disease
33%
Inflammation
33%
Rat Model
33%
Neovascularization (Pathology)
33%
Porcine Model
33%
Biochemistry, Genetics and Molecular Biology
Human Induced Pluripotent Stem Cell
100%